REGENERON PHARMACEUTICALS, INC.: accounts_payable
| Value | {"amount": 589200000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-12-31) |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/30bf8c73-5f74-45f7-93b4-09722dd1df2e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001804220-23-000008Retrieved: 2026-08-19T08:39:09.179697+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/accounts-payable/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/30bf8c73-5f74-45f7-93b4-09722dd1df2e
History
- no predecessors — first report